3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Non-Small Cell Lung Cancer ALK-positive
1
Neurofibromatosis 1
1
Hereditary Sensory and Autonomic Neuropathies
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
venetoclax
28
Cytarabine
25
Azacitidine
23
Specimen Handling
21
fludarabine
15
Biopsy
13
Injections
12
Daunorubicin
11
Cyclophosphamide
11
fludarabine phosphate
10
decitabine and cedazuridine drug combination
9
Whole-Body Irradiation
9
CPX-351
8
Mycophenolic Acid
7
Idarubicin
7
Granulocyte Colony-Stimulating Factor
7
Gemtuzumab
7
ivosidenib
6
Tacrolimus
6
Stem Cell Transplantation
6
Filgrastim
6
Busulfan
6
enasidenib
5
X-Rays
5
Melphalan
5
Etoposide
5
Decitabine
5
Cyclosporine
5
ruxolitinib
4
olutasidenib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
lorlatinib
×
30 days
×
Clear all
No trials found.